Languages Available
 
C

PT. Darya-Varia Laboratoria Tbk [DVLA]   IDR 1.955  0 (0,00%)


Loading...
DVLA IDR 1.955  0 (0,00%)
Last Update 16 October 2017 04:00 PM
Open
IDR 2.000
Prev Close
IDR 1.955
Offer
IDR 2.030
Bid
IDR 1.880
Day Low
IDR 1.955
Day High
IDR 2.030
Volume
225 Lots (22.500 Shares)
Value (IDR)
44,10 M
Frequency
10 (Times)
EPS (IDR)
216,21
PE Ratio (ttm)
9,39 %
Market Cap. (IDR)
2.189.600,00 M
Market Cap. Rank in Industry
#7 of 11 Companies in Pharmaceuticals
Market Cap. Rank in All Companies
#244 of 577 Companies
F
Net Foreign

This section of IDNFinancials requires you to sign up as a premium member of IDNFinancials.

Please check our pricing page to see all of our features.
O
Overview


PT Darya-Varia Laboratoria Tbk (DVLA) is engaged in the manufacture and trade of pharmaceutical products and cosmetics. The Company started commercial operations in 1976. The Company, through its parent entity, Blue Sphere Singapore Pte Ltd, is an affiliate of United Laboratories Inc, a pharmaceutical company based in the Philippines.

 

Source: www.darya-varia.com

Subsidiary Affiliation
 
Company Name
Percentage
1.
PT. Pabrik Obat Dupa
99,90 %
G
Management
Commissioners
-
President Commissioner
Vice President Commissioner
Commissioner
Independent Commissioner
Darodjatun Sanusi
Independent Commissioner
Independent Commissioner
Directors
-
President Director
Vice President Director
Director
Alex Espenilla Manlapas
Director
Roen Libarnes De Leon
Independent Director
Graph goes here...
S
Shareholders
No. Shareholder Name Number of Shares Total Paidup Capital Percentage
1. Blue Sphere Singapore Pte Ltd 1.031.800.912 IDR 257.950.228.000 92,46 %
2. Public (each below 5%) 84.124.388 IDR 21.031.097.000 7,54 %
3. Treasury stock 4.074.700 IDR 1.018.675.000 -
V
Videos
IDNFinancials Video - Darya expects increased performance by 2016
26 May 2016 03:48 PM
JAKARTA - PT Darya Varia Laboratoria Tbk (DVLA) expects the purchasing power of consumers in Indonesia to increase, which will impact the company’s revenue in 2016...
IDNFinancials Video - Darya claims 10% prescription increase but financial statement suggests otherwise
26 May 2016 03:42 PM
JAKARTA – PT Darya Varia Laboratoria Tbk (DVLA) claimed they noted prescription products sales increase in the first quarter 2016 compared with the same period in 2016...
A
Announcement
Darya Varia Laboratoria distributes interim dividend amounted Rp 35 per share cum August 24, 2017
2017-08-18 15:35:40
Links: [1]
Darya Varia Laboratoria distributes cash dividend Rp 65 per share Cum June 13, 2017
2017-06-06 13:15:25
Links: [1]
Darya-Varia Laboratoria pays dividend Rp35 per share cum June 1, 2016
2016-05-26 23:50:41
Links: [1]
Darya-Varia Laboratoria will hold annual shareholders' meeting on May 25, 2016
2016-04-18 23:30:37
Links: [1] [2]
Darya-Varia Laboratoria pays dividend Rp. 30 per share cum September 14, 2015
2015-09-08 23:30:22
Links: [1] [2] [3]
S
Financial
Period Revenue Net Profit
Q2 - 2017 394.344 M 37.500 M
Q1 - 2017 398.310 M 83.576 M
Q4 - 2016 299.994 M 14.693 M
Q3 - 2016 386.997 M 53.984 M
Q2 - 2016 385.053 M 26.828 M
Q1 - 2016 379.312 M 56.578 M
Q4 - 2015 321.164 M 10.142 M
Q3 - 2015 314.281 M 20.444 M
Full financial and operational data available to our premium users. Please check our premium data introduction page to learn more about our tools.